- Incidental discovery of a rectal polypoid lesion
-
Lee HS
- KMID: 2434169
- Intest Res.
- 2018 Oct;16(4):648-649.
- doi: 10.5217/ir.2018.00129
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lymph node macrophages: drug-related reaction or infectious-lesion?
-
Handra-Luca A
- KMID: 2434168
- Intest Res.
- 2018 Oct;16(4):646-647.
- doi: 10.5217/ir.2018.00065
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
-
Park JW, Kim TI, Cheon JH
- KMID: 2434167
- Intest Res.
- 2018 Oct;16(4):641-645.
- doi: 10.5217/ir.2018.00035
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
-
Kim YH
- KMID: 2434151
- Intest Res.
- 2018 Oct;16(4):507-508.
- doi: 10.5217/ir.2018.00136
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Magnified single-balloon enteroscopy in the diagnosis of intestinal follicular lymphoma: a case series
-
Takahashi , Bamba S, Kawahara M, Nishida A, Inatomi O, Sasaki M, Tsujikawa , Kushima R, Sugimoto M, Kitoh K, Andoh A
- KMID: 2434165
- Intest Res.
- 2018 Oct;16(4):628-634.
- doi: 10.5217/ir.2018.00003
The objective of this study was to evaluate the magnified endoscopic findings in the diagnosis of follicular lymphoma in the small intestine in comparison with those of intestinal follicular lymphoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
-
Kim DJ, Jeoun YM, Lee DW, Koo JS, Lee SW
- KMID: 2434158
- Intest Res.
- 2018 Oct;16(4):563-570.
- doi: 10.5217/ir.2018.00020
BACKGROUND/AIMS: Ulcerative colitis undergoes periods of exacerbation and remission. Fecal calprotectin levels increase with gut inflammation and correlate with endoscopic disease activity in ulcerative colitis. Intestinal blood loss and fecal... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease
-
Chew D, Zhiqin W, Ibrahim N, Ali RA
- KMID: 2434152
- Intest Res.
- 2018 Oct;16(4):509-521.
- doi: 10.5217/ir.2018.00074
The patient-physician relationship has a pivotal impact on the inflammatory bowel disease (IBD) outcomes. However, there are many challenges in the patient-physician relationship; lag time in diagnosis which results in... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and diversity of lactic acid producing bacteria and bifidobacteria in healthy full term Indian infants from Himachal Pradesh
-
Attri S, Mahajan R, Goel G
- KMID: 2434154
- Intest Res.
- 2018 Oct;16(4):529-536.
- doi: 10.5217/ir.2018.00050
BACKGROUND/AIMS: The initial microbial colonization is a crucial step for the healthy development of an infant. Previous studies from India reported the dominance of target microbial species among Indian infants... -
- CITED
-
- Close
- SHARE
-
- Close
- 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
-
Miyoshi J, Matsuoka K, Yoshida A, Naganuma M, Hisamatsu , Yajima T, Inoue N, Okamoto S, Iwao Y, Ogata H, Ueno F, Hibi T, Kanai T
- KMID: 2434166
- Intest Res.
- 2018 Oct;16(4):635-640.
- doi: 10.5217/ir.2018.00015
Ulcerative colitis (UC) is one of the major clinical phenotypes of inflammatory bowel diseases. Although 5-aminosalicylic acid (5-ASA) is widely used for UC and its efficacy and safety have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
-
Chang JY, Jung SA, Moon CM, Kim SE, Jung HK, Shim KN
- KMID: 2434162
- Intest Res.
- 2018 Oct;16(4):599-608.
- doi: 10.5217/ir.2018.00012
BACKGROUND/AIMS: Testing for hepatitis B virus (HBV) serologic markers and appropriate vaccination are required in the management of inflammatory bowel disease (IBD) patients. We evaluated immunogenicity for HBV in IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
-
Lam YF, Seto WK, Tong T, Cheung KS, Lo O, Hung IF, Law WL, Leung WK
- KMID: 2434164
- Intest Res.
- 2018 Oct;16(4):619-627.
- doi: 10.5217/ir.2018.00013
BACKGROUND/AIMS: We determined the rates of metachronous colorectal neoplasm in colorectal cancer (CRC) patients after resection for right (R)-sided or left (L)-sided cancer. METHODS: Consecutive CRC patients who had undergone surgical... -
- CITED
-
- Close
- SHARE
-
- Close
- Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis
-
Tsuda S, Kunisaki R, Kato J, Murakami M, Nishio M, Ogashiwa T, Yoshida T, Kimura H, Kitano M
- KMID: 2434160
- Intest Res.
- 2018 Oct;16(4):579-587.
- doi: 10.5217/ir.2018.00021
BACKGROUND/AIMS: In clinical practice, colonoscopy has been regarded as the gold standard for the evaluation of disease severity as well as mucosal healing in ulcerative colitis (UC). Some activity indices... -
- CITED
-
- Close
- SHARE
-
- Close
- Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
-
Wei SC, Tung CC, Weng MT, Wong JM
- KMID: 2434156
- Intest Res.
- 2018 Oct;16(4):546-553.
- doi: 10.5217/ir.2018.00052
BACKGROUND/AIMS: Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients with inflammatory bowel disease (IBD). Home fC tests are now available. We evaluated the performance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Medication non-adherence in inflammatory bowel diseases is associated with disability
-
Perry J, Chen A, Kariyawasam V, Collins G, Choong C, Teh WL, Mitrev N, Kohler F, Leong RW
- KMID: 2434159
- Intest Res.
- 2018 Oct;16(4):571-578.
- doi: 10.5217/ir.2018.00033
BACKGROUND/AIMS: Medication non-adherence is common in inflammatory bowel diseases (IBD). The short-term consequences of non-adherence include increased disease relapse but the long-term impact upon patients in terms of daily functional... -
- CITED
-
- Close
- SHARE
-
- Close
- IBD2020 global forum: results of an international patient survey on quality of care
-
Irving P, Burisch J, Driscoll R, Olsson M, Fullarton , Rodgers-Gray BS, Travis SP
- KMID: 2434155
- Intest Res.
- 2018 Oct;16(4):537-545.
- doi: 10.5217/ir.2018.00041
BACKGROUND/AIMS: IBD2020 is a global forum for standards of care in inflammatory bowel disease (IBD). The aim of the IBD2020 survey was to identify and describe variations in quality care... -
- CITED
-
- Close
- SHARE
-
- Close
- High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
-
Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Mouli VP, Dhingra R, Makharia G, Ahuja V
- KMID: 2434161
- Intest Res.
- 2018 Oct;16(4):588-598.
- doi: 10.5217/ir.2018.00023
BACKGROUND/AIMS: The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited. The risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
-
Nakamura S, Imaeda H, Nishikawa , Iimuro M, Matsuura M, Oka H, Oku J, Miyazaki T, Honda H, Watanabe K, Nakase H, Andoh A
- KMID: 2434157
- Intest Res.
- 2018 Oct;16(4):554-562.
- doi: 10.5217/ir.2018.00027
BACKGROUND/AIMS: Noninvasive objective monitoring is advantageous for optimizing treatment strategies in patients inflammatory bowel disease (IBD). Fecal calprotectin (FCP) is superior to traditional biomarkers in terms of assessing the activity... -
- CITED
-
- Close
- SHARE
-
- Close
- Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
-
Danese S, Banerjee R, Cummings J, Dotan I, Kotze PG, Leong RW, Paridaens , Peyrin-Biroulet L, Scott G, Assche GV, Wehkamp J, Yamamoto-Furusho JK
- KMID: 2434153
- Intest Res.
- 2018 Oct;16(4):522-528.
- doi: 10.5217/ir.2018.00073
Symptomatic ulcerative colitis (UC) can be a chronic, disabling condition. Flares in disease activity are associated with many of the negative impacts of mild-to-moderate UC. Rapid resolution of flares can... -
- CITED
-
- Close
- SHARE
-
- Close
- Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease
-
Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi , Oshita M, Tanaka H, Ozeki K, Takahashi , Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T
- KMID: 2434163
- Intest Res.
- 2018 Oct;16(4):609-618.
- doi: 10.5217/ir.2018.00044
BACKGROUND/AIMS: The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
